After 40 weeks of treatment, 4-mg, 9-mg and 12-mg doses of retatrutidean agonist of GLP-1, GIP and a third hormone, glucagon, aka triple Gdemonstrated average reductions in A1C of 1.7%, 1.9% and 1.9%, respectively, when accounting for all patients in the trial
Rapid Initial Loss (First Few Weeks) In the first two to four weeks, most people experience quick weight loss
If customs intercepts an international shipment, they may seize it
While maternal obesity can have a negative impact on the health of a pregnancy, weight loss during pregnancy including through weight loss medications is not recommended
Always inspect the injection for any particulate matter or discolouration before use
Specifications CAS number 170851-70-4 Molecular formula C38H49N9O5 Molecular weight 711.9 g/mol PubChem CID 9831659 InChIKey NEHWBYHLYZGBNO-BVEPWEIPSA-N For laboratory and research use only